SIMCERE PHARMAC. GRP LTD (S2P) — Defensive Interval Ratio
SIMCERE PHARMAC. GRP LTD (S2P) has a Defensive Interval Ratio of 279 days as of December 2025. Defensive assets of €2.56 Billion (cash €-, short-term investments €65.53 Million, receivables €2.49 Billion) cover 279 days of daily cash needs of €9.16 Million/day. See SIMCERE PHARMAC. GRP LTD current assets vs equity to evaluate short-term liquidity relative to the company's equity base.
Defensive Interval Ratio
Defensive Assets
Daily Cash Need
Current Liabilities
SIMCERE PHARMAC. GRP LTD Defensive Interval Ratio (2021–2025)
This chart shows how SIMCERE PHARMAC. GRP LTD's Defensive Interval Ratio has evolved across 5 annual periods from 2021 to 2025. As of December 2025, the ratio stands at 279 days, meaning defensive assets of €2.56 Billion can fund 279 days of operations without new revenue. See SIMCERE PHARMAC. GRP LTD net asset quality index to measure how much of total assets are equity-financed.
Annual Defensive Interval Ratio for SIMCERE PHARMAC. GRP LTD (2021–2025)
The table below presents the year-by-year Defensive Interval Ratio for SIMCERE PHARMAC. GRP LTD from 2021 to 2025, covering 5 annual filings. Each row shows defensive assets, daily cash need, the DIR in days, and the change in days compared to the prior year. For live market cap and the full company financial profile, see S2P market cap.
| Year | DIR (days) | Defensive Assets (EUR) | Daily Cash Need | Cash | ST Investments | Change (days) |
|---|---|---|---|---|---|---|
| 2025 | 279 days | €2.56 Billion | €9.16 Million/day | €- | €65.53 Million | ▼ -37 days |
| 2024 | 317 days | €2.36 Billion | €7.47 Million/day | €- | €10.00 Million | ▲ +44 days |
| 2023 | 273 days | €2.01 Billion | €7.36 Million/day | €- | €11.14 Million | ▼ -76 days |
| 2022 | 349 days | €2.84 Billion | €8.13 Million/day | €- | €964.23 Million | ▼ -35 days |
| 2021 | 384 days | €3.23 Billion | €8.39 Million/day | €- | €1.21 Billion | — |